Today the Food and Drug Administration approved Ampyra, a new drug owned by Biogen Idec. to fight multiple sclerosis.
The new drug is an extended-release tablet aimed at helping to increase mobility in those battling against multiple sclerosis. The FDA said those who took the drug had better movement and faster walking speeds than those who [...]

[Read more →]

Long-term sufferers of insomnia who have not found lasting relief from such sleep aids as Ambien or Sonata should consider researching Rozerem, the only medication of its type approved in the treatment of sleeplessness.
Rozerem (ramelteon) is the first of a new class of insomnia drugs: melatonin receptor agonists. These are similar to the naturally-produced sleep [...]

[Read more →]

A diagnosis of high cholesterol can be intimidating, but there is a lot you can do to control this condition. In addition to modifying your diet and upping your exercise, the addition of a HMG-CoA Reductase Inhibitor — a class of drugs commonly called “statins” — can safely and effectively lower your cholesterol. (HMG-CoA Reductase [...]

[Read more →]

Too many Americans today are basing their opinions on prescription drugs solely on advertising by drugmakers. You should never get all your information from pharmaceutical commercials, Web sites, or drug labels.
Why, you might ask? Aren’t drugmakers required by the FDA to tell the truth about their medications?
The answer is, yes and no. Drugmakers [...]

[Read more →]

Sometime back, Effect Measure posed a question many of us have pondered about direct-to-consumer (DTC) pharmaceutical commercials: What’s with the side-by-side bath tubs in the Cialis ads?
Here are some of the answers given in comments –

“Cialis really gets your pipes flowing or plumbing flowing…”
“Bathtubs — because you can’t show naked, mutually aroused adults on the [...]

[Read more →]

Consumers search for antidepressants online more than any other class of drug, according to data from comScore. In a recent study of 500,000 search queries, five of the 15 most frequently searched prescription brands were for depression. This is in keeping with our own search results at eDrugSearch.com.
Here are those five medications, in [...]

[Read more →]

Lipitor was the most frequently prescribed brand-name drug in the United States last year, with 50 million prescriptions being filled. Vytorin was right up there, with 20 million. Add in all the other statins and you’re up to an amazing 150 million.
As you might expect, we’ve had a fair amount of discussion in [...]

[Read more →]

Yeah, I know; I’ve written about this topic before — more than a few times. But I feel compelled to do so again. Frankly, I’m mad as heck and I can’t take it any more.
Just as there have been past hysterias blaming the Internet for sexual predators, pornography, political polarization, celebrity obsession, obesity [...]

[Read more →]

Jo Hartley reports:
“Health insurance companies are currently revising their pricing systems for very expensive drugs and they are now requiring patients to pay hundreds and sometimes thousands of dollars for prescriptions for drugs that may save their lives or slow the progress of serious diseases.
“With the new pricing system, insurers have now abandoned the traditional [...]

[Read more →]

It may be a mixed metaphor, but you get the point. This is how Georgia Congressman Jim Marshall describes the problem of high drug prices in this candid interview with Herbert Dennard.

[Read more →]